Although presentations with ACSs share common underlying pathophysiologic mechanisms ... presented with atypical symptoms. Coronary angiography and subsequent treatment with revascularization ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...

For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

When an acute coronary syndrome (ACS) with intra-coronary thrombosis ... Systemic venodilation, the predominant mechanism of action of nitroglycerin, results in decreased preload (stretching ...

What are the mechanisms? Are there novel treatments ... levels in statin-treated patients with acute coronary syndromes. Fewer statin-treated patients with LDL levels below 70 mg/dl had myocardial ...

The acute coronary syndromes include unstable angina ... mismatch between oxygen supply and demand by a pathophysiological mechanism other than coronary atherothrombosis” pathophysiology ...

Statin therapy reduces the risk of cardiovascular events in patients with coronary artery disease. Recent in vitro and in vivo studies demonstrated a LDL-independent action of these class of drugs ...

The rate of cardiovascular death, nonfatal heart attack, or nonfatal stroke was 30% lower among patients receiving nurse-led ...

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new ...

Elevated levels of cardiac troponin are associated with an increased risk of adverse cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes (ACS), but might not ...

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new findings to enable earlier detection of atherosclerosis and improved treatment ...